Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer

Daniel Gaitan, C. Rowan DeBold, Maxine K. Turney, Ping Zhou, David N. Orth, William J. Kovacs

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

ACTH secretion by tumors of nonpituitary origin is characteristically resistant to negative feedback regulation by glucocorticoids. One possible mechanism for the phenomenon could be a structural defect in the intracellular glucocorticoid receptor (GR). We studied the GR in DMS-79 cells derived from a human ACTH-secreting small cell lung cancer. Compared with control cells, DMS-79 cells were found to have greatly diminished GR ligand-binding activity and immunoreactive 94-kilodalton (kDa) GR content. Northern blot analysis revealed expression of GR transcripts that appeared to be slightly larger than those in control cells. A DMS-79 cell GR cDNA was cloned by reverse transcription/polymerase chain reaction amplification of mRNA using primers specific for full-length normal GR. The derived sequence of this full-length GR differed from the reported sequence by a single altered codon (G to A; Asn to Ser at codon 363) outside the steroid-binding domain. This N363S DMS-79 GR functioned normally to activate a target gene [mouse mammary tumor virus-chloramphenicol acetyl transferase (MMTV-CAT)] in transient transfection experiments in COS cells. Evidence for expression of a second type of GR mRNA was obtained by screening a DMS-79 cell cDNA library. This GR cDNA contained normal GR sequence up to nucleotide 2155, corresponding exactly to the end of exon 7 in the normal GR gene. The sequence appended to the GR sequences was not matched by any known sequence in DNA databases and included an in-frame termination codon after only 6 bases. The predicted truncated GR protein product (GR delta) has a mol wt of 73,740 and lacks most of the ligand-binding domain. Transient transfection of the GR delta form into COS cells did not reveal any dominant negative effect on the function of a cotransfected normal GR. GR signaling in DMS-79 cells could be restored by transient transfection with a normal GR cDNA. These data indicate that at least one GR allele is intact in DMS-79, that DMS-79 cells may produce the predominant truncated form of GR by aberrant splicing, and that the resultant diminution of normal GR expression may account for the clinically observed glucocorticoid-resistant state.

Original languageEnglish (US)
Pages (from-to)1193-1201
Number of pages9
JournalMolecular Endocrinology
Volume9
Issue number9
DOIs
StatePublished - Sep 1 1995
Externally publishedYes

Fingerprint

Glucocorticoid Receptors
Small Cell Lung Carcinoma
Adrenocorticotropic Hormone
Transfection
Complementary DNA
COS Cells
Codon
Glucocorticoids
Ligands
Mouse mammary tumor virus

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. / Gaitan, Daniel; DeBold, C. Rowan; Turney, Maxine K.; Zhou, Ping; Orth, David N.; Kovacs, William J.

In: Molecular Endocrinology, Vol. 9, No. 9, 01.09.1995, p. 1193-1201.

Research output: Contribution to journalArticle

Gaitan, Daniel ; DeBold, C. Rowan ; Turney, Maxine K. ; Zhou, Ping ; Orth, David N. ; Kovacs, William J. / Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. In: Molecular Endocrinology. 1995 ; Vol. 9, No. 9. pp. 1193-1201.
@article{e9f9861d649946d99ee69910695b29fc,
title = "Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer",
abstract = "ACTH secretion by tumors of nonpituitary origin is characteristically resistant to negative feedback regulation by glucocorticoids. One possible mechanism for the phenomenon could be a structural defect in the intracellular glucocorticoid receptor (GR). We studied the GR in DMS-79 cells derived from a human ACTH-secreting small cell lung cancer. Compared with control cells, DMS-79 cells were found to have greatly diminished GR ligand-binding activity and immunoreactive 94-kilodalton (kDa) GR content. Northern blot analysis revealed expression of GR transcripts that appeared to be slightly larger than those in control cells. A DMS-79 cell GR cDNA was cloned by reverse transcription/polymerase chain reaction amplification of mRNA using primers specific for full-length normal GR. The derived sequence of this full-length GR differed from the reported sequence by a single altered codon (G to A; Asn to Ser at codon 363) outside the steroid-binding domain. This N363S DMS-79 GR functioned normally to activate a target gene [mouse mammary tumor virus-chloramphenicol acetyl transferase (MMTV-CAT)] in transient transfection experiments in COS cells. Evidence for expression of a second type of GR mRNA was obtained by screening a DMS-79 cell cDNA library. This GR cDNA contained normal GR sequence up to nucleotide 2155, corresponding exactly to the end of exon 7 in the normal GR gene. The sequence appended to the GR sequences was not matched by any known sequence in DNA databases and included an in-frame termination codon after only 6 bases. The predicted truncated GR protein product (GR delta) has a mol wt of 73,740 and lacks most of the ligand-binding domain. Transient transfection of the GR delta form into COS cells did not reveal any dominant negative effect on the function of a cotransfected normal GR. GR signaling in DMS-79 cells could be restored by transient transfection with a normal GR cDNA. These data indicate that at least one GR allele is intact in DMS-79, that DMS-79 cells may produce the predominant truncated form of GR by aberrant splicing, and that the resultant diminution of normal GR expression may account for the clinically observed glucocorticoid-resistant state.",
author = "Daniel Gaitan and DeBold, {C. Rowan} and Turney, {Maxine K.} and Ping Zhou and Orth, {David N.} and Kovacs, {William J.}",
year = "1995",
month = "9",
day = "1",
doi = "10.1210/mend.9.9.7491111",
language = "English (US)",
volume = "9",
pages = "1193--1201",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer

AU - Gaitan, Daniel

AU - DeBold, C. Rowan

AU - Turney, Maxine K.

AU - Zhou, Ping

AU - Orth, David N.

AU - Kovacs, William J.

PY - 1995/9/1

Y1 - 1995/9/1

N2 - ACTH secretion by tumors of nonpituitary origin is characteristically resistant to negative feedback regulation by glucocorticoids. One possible mechanism for the phenomenon could be a structural defect in the intracellular glucocorticoid receptor (GR). We studied the GR in DMS-79 cells derived from a human ACTH-secreting small cell lung cancer. Compared with control cells, DMS-79 cells were found to have greatly diminished GR ligand-binding activity and immunoreactive 94-kilodalton (kDa) GR content. Northern blot analysis revealed expression of GR transcripts that appeared to be slightly larger than those in control cells. A DMS-79 cell GR cDNA was cloned by reverse transcription/polymerase chain reaction amplification of mRNA using primers specific for full-length normal GR. The derived sequence of this full-length GR differed from the reported sequence by a single altered codon (G to A; Asn to Ser at codon 363) outside the steroid-binding domain. This N363S DMS-79 GR functioned normally to activate a target gene [mouse mammary tumor virus-chloramphenicol acetyl transferase (MMTV-CAT)] in transient transfection experiments in COS cells. Evidence for expression of a second type of GR mRNA was obtained by screening a DMS-79 cell cDNA library. This GR cDNA contained normal GR sequence up to nucleotide 2155, corresponding exactly to the end of exon 7 in the normal GR gene. The sequence appended to the GR sequences was not matched by any known sequence in DNA databases and included an in-frame termination codon after only 6 bases. The predicted truncated GR protein product (GR delta) has a mol wt of 73,740 and lacks most of the ligand-binding domain. Transient transfection of the GR delta form into COS cells did not reveal any dominant negative effect on the function of a cotransfected normal GR. GR signaling in DMS-79 cells could be restored by transient transfection with a normal GR cDNA. These data indicate that at least one GR allele is intact in DMS-79, that DMS-79 cells may produce the predominant truncated form of GR by aberrant splicing, and that the resultant diminution of normal GR expression may account for the clinically observed glucocorticoid-resistant state.

AB - ACTH secretion by tumors of nonpituitary origin is characteristically resistant to negative feedback regulation by glucocorticoids. One possible mechanism for the phenomenon could be a structural defect in the intracellular glucocorticoid receptor (GR). We studied the GR in DMS-79 cells derived from a human ACTH-secreting small cell lung cancer. Compared with control cells, DMS-79 cells were found to have greatly diminished GR ligand-binding activity and immunoreactive 94-kilodalton (kDa) GR content. Northern blot analysis revealed expression of GR transcripts that appeared to be slightly larger than those in control cells. A DMS-79 cell GR cDNA was cloned by reverse transcription/polymerase chain reaction amplification of mRNA using primers specific for full-length normal GR. The derived sequence of this full-length GR differed from the reported sequence by a single altered codon (G to A; Asn to Ser at codon 363) outside the steroid-binding domain. This N363S DMS-79 GR functioned normally to activate a target gene [mouse mammary tumor virus-chloramphenicol acetyl transferase (MMTV-CAT)] in transient transfection experiments in COS cells. Evidence for expression of a second type of GR mRNA was obtained by screening a DMS-79 cell cDNA library. This GR cDNA contained normal GR sequence up to nucleotide 2155, corresponding exactly to the end of exon 7 in the normal GR gene. The sequence appended to the GR sequences was not matched by any known sequence in DNA databases and included an in-frame termination codon after only 6 bases. The predicted truncated GR protein product (GR delta) has a mol wt of 73,740 and lacks most of the ligand-binding domain. Transient transfection of the GR delta form into COS cells did not reveal any dominant negative effect on the function of a cotransfected normal GR. GR signaling in DMS-79 cells could be restored by transient transfection with a normal GR cDNA. These data indicate that at least one GR allele is intact in DMS-79, that DMS-79 cells may produce the predominant truncated form of GR by aberrant splicing, and that the resultant diminution of normal GR expression may account for the clinically observed glucocorticoid-resistant state.

UR - http://www.scopus.com/inward/record.url?scp=0029086783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029086783&partnerID=8YFLogxK

U2 - 10.1210/mend.9.9.7491111

DO - 10.1210/mend.9.9.7491111

M3 - Article

VL - 9

SP - 1193

EP - 1201

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 9

ER -